期刊文献+

超声在预测乳腺癌新辅助化疗后病理完全缓解中的应用价值

Application Value of Ultrasonography in Prediction of Pathological Complete Response of Breast Cancer after Neoadjuvant Chemotherapy
下载PDF
导出
摘要 目的:探讨超声在预测乳腺癌新辅助化疗后病理完全缓解中的应用价值。方法:回顾性分析21例经手术证实病理完全缓解的乳腺癌患者的临床资料及超声图像,观察病灶的大小、形态、边界、内部回声及血流分布情况的变化。结果:超声预测病理完全缓解12例。结论:超声在预测乳腺癌新辅助化疗后是否病理完全缓解中有重要作用。 Objective:To explore the application value of ultrasonography in prediction of pathological complete response in breast cancer patients underwent neoadjuvant chemotherapy.Method:The ultrasonographic images and clinical data of 21 cases of patients with pathologic complete response were reviewed.The focal size,shape,border,internal echo and blood flow distribution were observed.Result:Ultrasonography predicted 12 cases of pathological complete response.Conclusion:Ultrasonography plays an important role in prediction of pathological complete response in breast cancer after neoadjuvant chemotherapy.
作者 许伶俐 李毅
出处 《中外医学研究》 2016年第18期39-40,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 超声 乳腺癌 新辅助化疗 Ultrasonography Breast cancer Neoadjuvant chemotherapy
  • 相关文献

参考文献3

二级参考文献27

  • 1朱庆莉,姜玉新,孙强,周炜洵.乳腺癌的彩色多普勒血流分布特征与组织病理学对照研究[J].中国医学影像技术,2005,21(10):1516-1518. 被引量:41
  • 2罗慧,罗奕伦,姜燕,冯晓凤,焦阳,彭启慧,彭树松.超声造影增强强度在乳腺肿块诊断中的价值[J].中国超声医学杂志,2007,23(2):107-110. 被引量:33
  • 3Ogston KN, Miller 1D, Payne S, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast, 2003, 12(5): 320-327.
  • 4Duffaud F, Therasse P. New guidelines to evaluate the response to treatment in solid tumors. Bull Cancer, 2000, 87(12): 881-886.
  • 5Keune JD, Jeffe DB, Schootman M, et al. Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer. Am J Surg, 2010, 199(4): 477-484.
  • 6E.A. Eisenhauer,P. Therasse,J. Bogaerts,L.H. Schwartz,D. Sargent,R. Ford,J. Dancey,S. Arbuck,S. Gwyther,M. Mooney,L. Rubinstein,L. Shankar,L. Dodd,R. Kaplan,D. Lacombe,J. Verweij.New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)[J]. European Journal of Cancer . 2008 (2)
  • 7Cuppone F,Bria E,Carlini P,et al.Taxanes as primary chemotherapy for early breast cancer:meta-analysis of randomized trials[J].Cancer,2008,113(2):238-246.
  • 8Hong WS,Jeon JY,Kang SY,et al.Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin,cyclophosphamide followed by paclitaxel in patients with operable breast cancer[J].J Korean Surg Soc,2013,85(1):7-14.
  • 9Untch M,Mbus V,Kuhn W,et al.Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer[J].J Clin Oncol,2009,27(18):2938-2945.
  • 10Buzdar AU,Valero V,Ibrahim NK,et al.Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil,epirubicin,and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer:an update of the initial randomized study population and data of additional patients treated with the same regimen[J].Clin Cancer Res,2007,13(1):228-233.

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部